Antigua and Barbuda vs Europe & Central Asia (IDA & IBRD countries): Immunization, Hib3
Immunization, Hib3 over time
- Antigua and Barbuda
- Europe & Central Asia (IDA & IBRD countries)
How they compare
Antigua and Barbuda currently reports 99.0% against 93.4% in Europe & Central Asia (IDA & IBRD countries), a difference of 5.6%.
That makes Antigua and Barbuda's figure about 1.1 times Europe & Central Asia (IDA & IBRD countries)'s.
Across all 24 years both countries report, Antigua and Barbuda has been ahead every year.
Antigua and Barbuda ranks 1st and Europe & Central Asia (IDA & IBRD countries) ranks 3rd of 191 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Europe & Central Asia (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.3% | 14.7% | 82.6% | Antigua and Barbuda |
| 2010s | 97.3% | 64.0% | 33.3% | Antigua and Barbuda |
| 2020s | 97.4% | 83.7% | 13.7% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Antigua and Barbuda or Europe & Central Asia (IDA & IBRD countries)?
- Antigua and Barbuda, at 99.0% against 93.4% in Europe & Central Asia (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Antigua and Barbuda and Europe & Central Asia (IDA & IBRD countries)?
- 5.6%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Europe & Central Asia (IDA & IBRD countries)?
- 24 years are reported by both, from 2001 to 2024.
- How do Antigua and Barbuda and Europe & Central Asia (IDA & IBRD countries) rank globally for immunization, hib3?
- Antigua and Barbuda ranks 1st and Europe & Central Asia (IDA & IBRD countries) ranks 3rd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.